New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Take the survey

›ETF Issuers›Leverage Shares›1ARKG

1ARKG

Leverage Shares 1x ARK Genomic Tracker ETP

Active ETP Equity Theme: BioTech & Genomics

Not rated

The 1ARKG Exchange Traded Product (ETP) is provided by Leverage Shares. This fund is actively managed; it does not track an index. The dividend policy is capitalization.

€2.95

+€0.02 (+0.68%) today

7:04 AM 07/16/26 Open

1D price range

€2.95€2.95

52W price range

€1.89€3.55

YTD Perf.

+42.01%

YTD Flows

Annualized volatility

Fund AuM

€966K

Share class AuM

€966K

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

XS2399368062

TER

1.1%

Inception date

12/14/2021

Issuer

Leverage Shares

Dividend policy

Capitalization

Compare similar ETFs

No content available for this fund

API

PerformanceDec 31, 2025 - Jul 15, 2026

Flows

Join for free to unlock

Sector exposures

No content available for this fund

Latest 1ARKG news

Biotech Funds Underperform the Broader Market

Moving Markets · March 12, 2024

FAQ about 1ARKG

1ARKG is a Active ETF. This ETP provides exposure to Other Equities.

1ARKG carries a total expense ratio (TER) of 1.1%, indicating the annual cost for holding the fund.

1ARKG was introduced to the market on December 14, 2021. It trades on Germany, among other exchanges

Leverage Shares 1x ARK Genomic Tracker ETP, 1ARKG, is provided by Leverage Shares. Learn more about Leverage Shares here.

1ARKG oversees €966K in assets as of July 15, 2026.

1ARKG follows a capitalizing, meaning it reinvests income within the fund.

The base currency of 1ARKG is USD.

Top 10 holdings

No content available for this fund

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The ETF Industry Is Evolving Fast

Leverage Shares 1x ARK Genomic Tracker ETP

FAQ about 1ARKG

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US